3 niðurstöður
Despite the increase in cognitive deficit following stroke in metabolic syndrome (MetS) condition, the therapeutic strategy is still limited. Since oxidative stress and neuroinflammation play the crucial roles on the pathophysiology of aforementioned conditions, the cognitive enhancing effect of the
The novel strategy against ischemic stroke in metabolic syndrome (MetS) targeting at oxidative stress and inflammation has gained attention due to the limitation of the current therapy. Due to the antioxidant and anti-inflammation of the combined extract of Oryza sativa and Anethum
Background: Obesity is a common health concern among all populations and age groups worldwide and is a risk factor that leads to a significant increase in mortality and cardiovascular diseases, type 2 diabetes, metabolic syndrome, stroke,